Bone mineral density in Iranian patients with inflammatory bowel disease

被引:0
|
作者
Mohammadreza Zali
Ali Bahari
Farzad Firouzi
Nasser Ebrahimi Daryani
Rahim Aghazadeh
Mohammad Mehdi Emam
Ali Rezaie
Hamid Mohaghegh Shalmani
Nosratollah Naderi
Baharak Maleki
Alireza Sayyah
Mohammad Bashashati
Haniehsadat Jazayeri
Shima Zand
机构
[1] Shaheed Beheshti University of Medical Sciences,Department of Inflammatory Bowel Disease, Research Center for Gastroenterology and Liver Diseases
[2] Zahedan University of Medical Sciences,Department of Gastroenterology
[3] Tehran University of Medical Sciences,Department of Gastroenterology
[4] Shaheed Beheshti University of Medical Sciences,Department of Rheumatology
[5] Taleghani Hospital,Research Center for Gastroenterology and Liver Disease
关键词
Inflammatory bowel disease; Bone mineral density; Corticosteroid;
D O I
暂无
中图分类号
学科分类号
摘要
Patients with inflammatory bowel disease (IBD) are at increased risk of developing osteopenia and osteoporosis. The aim of the study was to investigate the prevalence of decreased bone density and related risk factors in Iranian IBD patients. A total of 126 ulcerative colitis (UC) and 39 Crohn’s disease (CD) patients were enrolled. Dual-energy x-ray absorptiometry technique was used to measure bone density, and blood samples were obtained to measure biochemical markers. To find predictive variables for bone mineral density (BMD), stepwise regression analysis was carried out. A total of 53 IBD patients (32.1%) had diminished bone mineral density at either lumbar spine (L1–L4) or femoral neck. Of these, 9 (5.4%) had osteoporosis; however, 44 (26.7%) were osteopenic. Femoral neck bone density was significantly decreased among CD patients (p<0.04). There was no significant difference in BMD between men and women. We have found significant differences in BMD T scores at lumbar L1–L4, L2–L4, and femoral neck in corticosteroid ever-users (p<0.002, p<0.001, p<0.003, respectively). There was no significant difference in biochemical markers between UC and CD patients, except that more CD patients were hypocalcemic (p<0.001). Stepwise regression analysis has revealed lumbar spine T score was predicted by age (p<0.0001), corticosteroid use (p<0.002), and body mass index (BMI) (p<0.005); however, femoral neck was predicted by age (p<0.0001), BMI (p<0.0001), smoking (p<0.009), and corticosteroid use (p<0.028). Low bone density in Iranian UC and CD patients is in accordance with Western societies. Treatment with corticosteroid has increased this possibility in both groups. Corticosteroid use, age, smoking, and BMI are predictive factors for low bone density.
引用
收藏
页码:758 / 766
页数:8
相关论文
共 50 条
  • [1] Bone mineral density in Iranian patients with inflammatory bowel disease
    Zali, Mohammadreza
    Bahari, Ali
    Firouzi, Farzad
    Daryani, Nasser Ebrahimi
    Aghazadeh, Rahim
    Emam, Mohammad Mehdi
    Rezaie, Ali
    Shalmani, Hamid Mohaghegh
    Naderi, Nosratollah
    Maleki, Baharak
    Sayyah, Alireza
    Bashashati, Mohammad
    Jazayeri, Haniehsadat
    Zand, Shima
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2006, 21 (08) : 758 - 766
  • [2] Bone mineral density in Iranian patients with inflammatory bowel disease
    Firouzi, F
    Zali, MR
    Bahari, A
    Daryani, NE
    Aghazadeh, R
    Emam, MM
    Rezaie, A
    Shalmani, HM
    Naderi, N
    Maleki, B
    Sayyah, AR
    Beshashati, M
    Zand, S
    Jazayeri, H
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S301 - S301
  • [3] Bone mineral density in Iranian patients with inflammatory bowel disease
    Bahari, A
    Zali, MR
    Aghazadeh, R
    Emam, MM
    Daryani, NE
    Mirmajlesi, SH
    Maleki, B
    Rezaie, A
    Shalmani, HM
    Firouzi, F
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S256 - S257
  • [4] EVALUATION OF BONE MINERAL DENSITY IN IRANIAN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Iravani, S.
    Nourian, M.
    Beygi, Z. Abbas
    Riyazi, P.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S627 - S627
  • [5] Bone mineral density in patients with inflammatory bowel disease
    Martin, JP
    Tonge, KA
    Bhonsle, U
    Jacyna, MR
    Levi, J
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1999, 11 (05) : 537 - 541
  • [6] Bone mineral density in patients with inflammatory bowel disease
    Ben Hamida, KS
    Kedadi, H
    Bougasssas, W
    Ben Cheikh, M
    Ksontini, I
    Mestiri, A
    Smida, H
    Bouhaoula, H
    Dougui, MH
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 514 - 514
  • [7] Low bone mineral density in patients with inflammatory bowel disease
    Kmecova, Z.
    Payer, J.
    Killinger, Z.
    Rovensky, J.
    Svac, J.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S315 - S315
  • [8] The change of bone mineral density in patients with inflammatory bowel disease
    Moon, Won
    Jeong, Joon Ho
    Park, Seun Ja
    Kim, Jae Hyun
    Park, Moo In
    Kim, Sung Eun
    Jung, Kyung Won
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 468 - 468
  • [9] The change of bone mineral density in patients with inflammatory bowel disease
    Moon, W.
    Park, S. J.
    Park, M. I.
    Kim, S. E.
    Kim, J. H.
    Jung, K.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S248 - S248
  • [10] Bone mineral density evaluation in patients with inflammatory bowel disease
    Lora, FL
    Borba, VZC
    Kulak, CAM
    Pisani, JC
    Carmes, ER
    Miasaki, FY
    Amarante, HMB
    [J]. OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S77 - S77